Russell Skibsted, Chief Financial Officer at BIOTIME INC (BTX), bought 2,000 shares at $2.64 ($5K) on 2017-08-23, disclosed to the SEC on 2017-08-25.
Open-market purchase of $5k BTX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PCSA | BUY | 2026-06-01 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $6K | — | Filing → |